HEALTH● LOWSep 2 · Sep 2, 2026, 12:24 PM
United Therapeutics bid to expand nebulized Tyvaso label gets FDA review
Seeking Alpha Tech · north america
United Therapeutics' request to expand the label for nebulized Tyvaso is under review by the FDA. This indicates a potential broadening of the drug's approved uses.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH35m agoUCH resident doctors suspend warning strikeVanguard NigeriaHEALTH48m agoKatsina health professionals declare 7-day warning strikePremium TimesHEALTH1h agoPope Leo XIV has 'good night' in hospital after lung surgery, Vatican saysEuroNews [en]HEALTH1h agoWHO Urges Action On Lead Poisoning DangersChannels TV